apo, apolipoprotein
Donor splice site mutation in the apolipoprotein (Apo) C II gene (Apo C IIHamburg) of a patient with Apo C II deficiency
7
Serum prostacyclin stabilizing factor is identical to apolipoprotein A I (Apo A I) A novel function of Apo A I
6
Paediatric dyslipidemia as a predictor of dyslipidemia and carotid artery thickening in young adults : findings from the Childhood Determinants of Adult Health (CDAH) Study, the Cardiovascular Risk in Young Finns Study, and the Bogalusa Heart Study
316
The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
8
Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo
8
Association between single nucleotide polymorphism rs11057401 of CCDC92 gene and the risk of coronary heart disease (CHD)
5
Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis
10
Apolipoprotein E2 Christchurch (136 Arg Ser) New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia
9
Structural relationship of human apolipoprotein B48 to apolipoprotein B100
6
Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study
8
Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism Studies in transgenic mice
11
Epitopes of apolipoprotein B 100 and B 48 in both liver and intestine Expression and evidence for local synthesis in recessive abetalipoproteinemia
9
IMMUNOGENETIC POLYMORPHISM OF LIPOPROTEINS IN SWINE: GENETIC, IMMUNOLOGICAL AND PHYSIOCHEMICAL CHARACTERIZATION OF THE TWO ALLOTYPES LPR1 AND LPR2
23
Apo E structure determines VLDL clearance and atherosclerosis risk in mice
9
Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects
8
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
12
New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia
10
Immune complex hyperlipidemia induced by an apolipoprotein reactive immunoglobulin A paraprotein from a patient with multiple myeloma Characterization of this immunoglobulin
9
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
10
Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins
12